letter

Vaxart Granted Extension by Nasdaq to Regain Compliance

August 29, 2025 08:00 ET  | Source: Vaxart, Inc. - Company must regain compliance with the Nasdaq Bid Price Rule…

1 week ago

Ancora Issues Letter to CSXs Board of Directors Regarding the Need to Avert a Permanent Impairment of Value and Aggressively Pursue a Value-Maximizing Merger

Asserts the Board Should Immediately Announce the Formal Retention of an Investment Bank and Plan to Vigorously Explore Mergers as…

2 weeks ago

IOC reaffirms commitment to advancing sustainable development through sport at the local level

25 July 2025 - Building on its ongoing efforts to support sustainable development through sport, the International Olympic Committee (IOC) has…

1 month ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

2 months ago

Prime Success Responds to Sinovac Biotechs False and Misleading Claims

For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder…

3 months ago

Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F

June 02, 2025 19:30 ET  | Source: Semilux International Ltd. Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International…

3 months ago